SequelSEC

LFTD PARTNERS INC. LIFD

Pharmaceutical Preparations · CIK 0001391135 · Fiscal year ends 1231

Revenue
$35.34M
Fiscal year ended 2026-06-30
Operating income
-$4.74M
Fiscal year ended 2026-06-30
Free cash flow
$963.19K
Fiscal year ended 2026-06-30

LFTD PARTNERS INC. (LIFD) reported revenue of $35.34M and net income of -$29.88M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from LFTD PARTNERS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

LFTD PARTNERS INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$35.34M
Cost of revenue$29.23M
Gross profit$6.10M
Operating income-$4.74M
Net income-$29.88M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$30.08M
Income tax expense-$194.45K
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

LFTD PARTNERS INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$12.03M
Current assets$9.38M
Total liabilities$5.00M
Current liabilities$3.65M
Total equity incl. NCI$7.03M
Temporary (mezzanine) equityUnavailable
Inventory$3.46M
Accounts receivable$2.92M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

LFTD PARTNERS INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$1.14M
Capital expenditures$176.09K
Investing cash flow-$176.09K
Financing cash flow-$2.57M
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$309.32K

Derived

LFTD PARTNERS INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$963.19K
Gross margin17.3%
Operating margin-13.4%
FCF margin2.7%
SBC / revenueUnavailable
Current ratio2.57x
Revenue YoY growth-3.5%
Net margin-84.6%
R&D / revenueUnavailable
CapEx / revenue0.5%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LIFD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-04-01View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.